Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04829799

Effect of Intracameral Phenylephrine/Ketorolac on Intraoperative Pain

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Florida · Academic / Other
Sex
All
Age
40 Years – 95 Years
Healthy volunteers
Not accepted

Summary

To compare the effect of intraoperative intracameral Omidria (Phenylephrine and Ketorolac 1.0%/0.3%) verses 1% Lidocaine on pain reduction during and after cataract surgery.

Conditions

Interventions

TypeNameDescription
DRUG1% preservative-free lidocaineInstillation of intracameral lidocaine after initial paracentesis incision.
DRUGPhenylephrine 1.0%/ Ketorolac 0.3%Instillation of Omidria irrigation solution after paracentesis incision and in irrigation solution.

Timeline

Start date
2022-02-01
Primary completion
2023-08-01
Completion
2023-08-01
First posted
2021-04-02
Last updated
2022-06-13

Regulatory

Source: ClinicalTrials.gov record NCT04829799. Inclusion in this directory is not an endorsement.